全文获取类型
收费全文 | 8100篇 |
免费 | 524篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 266篇 |
妇产科学 | 160篇 |
基础医学 | 1379篇 |
口腔科学 | 457篇 |
临床医学 | 620篇 |
内科学 | 1759篇 |
皮肤病学 | 213篇 |
神经病学 | 706篇 |
特种医学 | 100篇 |
外科学 | 896篇 |
综合类 | 32篇 |
一般理论 | 4篇 |
预防医学 | 725篇 |
眼科学 | 155篇 |
药学 | 549篇 |
中国医学 | 50篇 |
肿瘤学 | 506篇 |
出版年
2024年 | 6篇 |
2023年 | 66篇 |
2022年 | 184篇 |
2021年 | 307篇 |
2020年 | 193篇 |
2019年 | 247篇 |
2018年 | 311篇 |
2017年 | 187篇 |
2016年 | 233篇 |
2015年 | 240篇 |
2014年 | 371篇 |
2013年 | 484篇 |
2012年 | 712篇 |
2011年 | 737篇 |
2010年 | 397篇 |
2009年 | 313篇 |
2008年 | 596篇 |
2007年 | 537篇 |
2006年 | 498篇 |
2005年 | 414篇 |
2004年 | 400篇 |
2003年 | 376篇 |
2002年 | 333篇 |
2001年 | 35篇 |
2000年 | 32篇 |
1999年 | 49篇 |
1998年 | 53篇 |
1997年 | 36篇 |
1996年 | 31篇 |
1995年 | 26篇 |
1994年 | 24篇 |
1993年 | 17篇 |
1992年 | 22篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 21篇 |
1988年 | 24篇 |
1987年 | 14篇 |
1986年 | 14篇 |
1985年 | 11篇 |
1984年 | 13篇 |
1983年 | 9篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1969年 | 2篇 |
排序方式: 共有8671条查询结果,搜索用时 250 毫秒
991.
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness 总被引:5,自引:0,他引:5
992.
De La Rocha A Sucato DJ Tulchin K Podeszwa DA 《Clinical orthopaedics and related research》2012,470(9):2583-2590
Background
Although the success of the Bernese periacetabular osteotomy (PAO) has been reported for primary dysplasia, there is no study analyzing the radiographic, functional, and gait results of the PAO to correct residual hip dysplasia after previous pelvic surgery. 相似文献993.
994.
995.
996.
997.
998.
999.
Diana Fernández César Segura Margarita Arboleda Giovanny Garavito Silvia Blair Adriana Pabón 《Antimicrobial agents and chemotherapy》2014,58(11):6354-6359
The in vitro susceptibilities of 30 isolates of Plasmodium vivax to a number of antimalarials (chloroquine [CQ], mefloquine, amodiaquine, quinine, and artesunate [AS]) were evaluated. The isolates came from the region of Urabá in Colombia, in which malaria is endemic, and were evaluated by the schizont maturation test. The 50% inhibitory concentration (IC50) was 0.6 nM (95% confidence interval [CI], 0.3 to 1.0 nM) for artesunate, 8.5 nM (95% CI, 5.6 to 13.0 nM) for amodiaquine, 23.3 nM (95% CI, 12.4 to 44.1 nM) for chloroquine, 55.6 nM (95% CI, 36.8 to 84.1 nM) for mefloquine, and 115.3 nM (95% CI, 57.7 to 230.5 nM) for quinine. The isolates were classified according to whether the initial parasites were mature or immature trophozoites (Tfz). It was found that the IC50s for chloroquine and artesunate were significantly different in the two aforementioned groups (P < 0.001). The IC50s of CQ and AS were higher in the isolates from mature Tfz (CQ, 39.3 nM versus 17 nM; AS, 1.4 nM versus 0.3 nM), and 10% of the isolates showed lower susceptibilities to one of the antimalarial drugs, 13.3% to two antimalarial drugs, and 3.3% to more than three antimalarial drugs. It should be highlighted that despite the extensive use of chloroquine in Colombia, P. vivax continues to be susceptible to antimalarials. This is the first report, to our knowledge, showing in vitro susceptibilities of P. vivax isolates to antimalarials in Colombia. 相似文献
1000.
Regina Fernandez Liliana I. Paz Roberto R. Rosato Adriana E. Rosato 《Antimicrobial agents and chemotherapy》2014,58(10):5736-5746
Methicillin-resistant Staphylococcus aureus (MRSA) is an important infectious human pathogen responsible for diseases ranging from skin and soft tissue infections to life-threatening endocarditis. β-Lactam resistance in MRSA involves acquisition of penicillin-binding protein 2a (PBP2a), a protein with low affinity for β-lactams that mediates cell wall assembly when the normal staphylococcal PBPs (PBP1 to -4) are blocked by these agents. Many MRSA strains display heterogeneous expression of resistance (HeR) against β-lactam antibiotics. The β-lactam-mediated homoresistant (HoR) phenotype is associated with both expression of the mecA gene and activation of the LexA-RecA-mediated SOS response, a regulatory network induced in response to DNA damage. Ceftaroline (CPT) is the only FDA-approved cephalosporin targeting PBP2a. We investigated the mechanistic basis of CPT activity against HeR-MRSA strains, including a set of strains displaying an intermediate level of resistance to CPT. Mechanistically, we found that 1 exposure of HeR-MRSA to subinhibitory concentrations of CPT selected for the HoR derivative activated the SOS response and increased mutagenesis. Importantly, CPT-selected HoR cells remained susceptible to CPT while still being resistant to most β-lactams, and 2-CPT activity in HeR-MRSA resided in an attenuated induction of mecA expression in comparison to other β-lactams. In addition, 3-CPT intermediate-resistant strains displayed a significant increase in CPT-induced mecA expression accompanied by mutations in PBP2, which together may interfere with the complete repression by CPT of both PBP2a and PBP2a-PBP2 interactions and thus be a determining factor in the low level of CPT resistance in the absence of mecA gene mutations. The present study provides mechanistic evidence that CPT represents an alternative therapeutic option for the treatment of heteroresistant MRSA strains. 相似文献